Since its founding in 2011, Zecen Biotech Co., Ltd. has been dedicated to the R&D and innovation of fully automated chemiluminescence total solutions. The company operates R&D centers and production bases in Beijing, Wuxi, and Taizhou, and its products have successfully entered international markets including Southeast Asia, the Middle East, and Latin America.

Guided by the mission "Using technology to reshape the rhythm of life", Zecen Biotech Co., Ltd. remains committed to continuous innovation, driving the advancement of precision medicine. With its customer call center based in Beijing and a service network spanning the country, the company has established a comprehensive after‑sales service system. From pre‑sales consultation to post‑sales maintenance, Zecen is devoted to providing attentive, professional, full‑lifecycle services to global customers—ensuring the reliable operation of every diagnostic instrument and delivering maximum value to our clients.

Zecen Biotech Co., Ltd. has offices in more than 40 countries and regions worldwide, and maintains resident after‑sales service engineers and clinical application engineers across over 30 provinces in China. The company boasts a professional and efficient technical support team of over 20 after‑sales engineers, covering three specialized areas: instrument hardware engineers, software customization engineers, and reagent clinical technical support engineers. Backed by the Beijing customer call center and a nationwide service network, we provide both remote and on‑site support, responding promptly to customer needs. Our products have been successfully introduced into multiple international markets, including Southeast Asia, the Middle East, Latin America, and Europe.

With over a decade of deep expertise in chemiluminescence immunoassay (CLIA), Zecen holds complete intellectual property rights for its intelligent diagnostic system based on tube‑based magnetic particle chemiluminescence immunoassay. The company focuses exclusively on servicing its own core products (instruments and matching reagents), ensuring high technical precision and specialization. We have obtained multiple Class III and Class II medical device registration certificates and hold more than 50 invention patents.

Our service processes strictly adhere to the ISO 13485 quality management system standards. Our instruments and supporting reagents have been audited by TÜV and successfully obtained EU CE certification in 2017. From product R&D to after‑sales service, the entire process is fully compliant and controllable, ensuring that our service quality meets international standards.